Holen Sie sich die Stockscreener-App
62.79
1.49%
0.92
Handel nachbörslich:
64.00
1.21
+1.93%
Schlusskurs vom Vortag:
$61.87
Offen:
$61.9
24-Stunden-Volumen:
1.56M
Relative Volume:
0.92
Marktkapitalisierung:
$8.48B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
46.86
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
+18.85%
1M Leistung:
+9.93%
6M Leistung:
-25.37%
1J Leistung:
-6.73%
1-Tages-Spanne:
$61.66
$63.11
1-Wochen-Bereich:
$52.69
$63.11
52-Wochen-Spanne:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
62.79 | 8.36B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand - Nasdaq
UFP Technologies, Inspire Medical Systems, Globus Medical, Neogen, and Dentsply Sirona stocks soar on positive inflation data, Fed rate cut hopes. - AInvest
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know - Yahoo Finance
Globus Medical (GMED) Receives Hold Rating from Truist Financial and Needham, Upgrade to Buy from TR | OpenAI – 4o - AInvest
Globus Medical, Inc. (NYSE:GMED) Q2 2025 Earnings Call Transcript - Insider Monkey
Is Globus Medical Inc. a defensive stockBest Profit-to-Risk Stocks - classian.co.kr
Quant Strategy Flags Globus Medical Inc. for EntryWeekly Chart Analysis With Entry Advice Provided - beatles.ru
Globus Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - 富途牛牛
Globus Medical Delivers Strong Q2 Results, Reaffirms 2025 Outlook - MSN
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $66 to $106 - 富途牛牛
Are Investors Undervaluing Globus Medical, Inc. (NYSE:GMED) By 43%? - Yahoo Finance
Globus Medical's Q2 2025 Earnings and Strategic Leadership Shifts: A Blueprint for Sustained Growth - AInvest
Globus Medical Surges 8.47% on $210M Volume as Q2 Sales Hit $745M Propelling It into Top 500 High-Volume Stocks - AInvest
Globus Medical: A Strategic Powerhouse in the Evolving Spine Care Landscape - AInvest
Globus Medical reaffirms $2.8B–$2.9B 2025 sales outlook as integration advances and U.S. Spine momentum builds - MSN
Globus Medical Reiterates $2.8B-$2.9B 2025 Sales Outlook Amid Integration Progress and Growing US Spine Market - AInvest
Globus Medical (GMED) Stock Rises on Better-Than-Expected Q2 ResultsNews and Statistics - IndexBox
How Globus Medical's (GMED) Surge in Net Income and Sales May Reshape Its 2025 Outlook - simplywall.st
Barclays raises Globus Medical stock price target to $106 on margin strength - Investing.com Canada
Globus Medical 2025 Q2 Earnings Record Net Income Surges 538.7% - AInvest
Globus Medical (GMED) Shares Skyrocket, What You Need To Know - TradingView
Transcript : Globus Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Globus Medical worldwide sales up 18.4% to USD 745.3M in Q2 2025 - Medical Buyer
Globus Medical (NYSE:GMED) Exceeds Q2 Expectations - Yahoo Finance
Globus Medical shares rise 6.90% premarket after Q2 sales, adjusted EPS beat expectations. - AInvest
Globus Medical Inc (GMED) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Globus Medical: Q2 Earnings Snapshot - Greenwich Time
Globus Medical Reports Strong Q2 2025 Growth - TipRanks
Globus Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight - GuruFocus
Globus Medical Q2 Earnings Top Consensus, Revenue Hits $745.3M - AInvest
Globus Medical Outperforms Expectations With Strong Q2 Results - Finimize
Globus Medical's Q2 2025 Earnings Outperformance: A Masterclass in Operational Execution and Strategic Innovation - AInvest
Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Globus Medical earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Globus Medical (GMED) Q2 Revenue Up 18% - The Globe and Mail
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Globus Medical Q2 sales, adjusted EPS beat expectations - MarketScreener
Globus Medical Q2 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Reaffirmed - MarketScreener
Globus Medical reports Q2 non-GAAP EPS 86c, consensus 75c - TipRanks
GLOBUS MEDICAL INC SEC 10-Q Report - TradingView
Why Globus Medical Shares Are Under Pressure - TipRanks
Globus Medical Reports Second Quarter 2025 Results - GlobeNewswire
Stay Ahead of the Game With Globus Medical (GMED) Q2 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Globus Medical (GMED) Earnings Preview: Key Insights for InvestorsNews and Statistics - IndexBox
Globus Medical (GMED) Q2 Earnings: What To Expect - Yahoo Finance
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years - 富途牛牛
Globus Medical GMED 2025Q2 Earnings Preview Upside Potential Driven by Reaffirmed Revenue Guidance - AInvest
How does Globus Medical Inc. compare to its industry peersGet insider insights into market trends - Jammu Links News
Does Globus Medical Inc. stock perform well during market downturnsMassive profits - Jammu Links News
What are Globus Medical Inc. company’s key revenue driversStrongest growth potential - Jammu Links News
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):